Published in Biotech Business Week, January 1st, 2007
This Frost & Sullivan research report provides in-depth information about the various commercial products and therapies for diabetes and related health complications, available in the market today and those on the verge of commercialization. Analysts examine the applications of drug therapy, insulin therapy, pancreas transplant, islet cell therapy, artificial pancreas, and gene therapy.
According to the research, the escalating rate of diabetes is encouraging the development of new therapies. The twin diseases of diabetes and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.